Clinilabs Drug Development Corporation

Eatontown, New Jersey 07724

3 studies enrolling now · 14 studies all time

What they study most

Arterial Calcification, Autosomal Recessive Hypophosphatemic Rickets, Autosomal Recessive Hypophosphatemic Rickets Type 2, Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Excessive Sleepiness, Friedreich Ataxia, Gene Mutations, Generalized Arterial Calcification of Infancy, Healthy, Healthy Volunteers, Major Depressive Disorder, OSA

Studies at this site

• Clinical Trials of Multivalent Opioid Vaccine Components — Recruiting now
• ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency — Recruiting now
• Multiple Ascending Dose Phase 1 Study of ALA-3000 — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency — Completed
• ANC-501 in the Treatment of Adults With Major Depressive Disorder — Completed
• A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ataxia — Completed
• A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder — Completed
• Safety, Tolerability, and Pharmacokinetics of IXT-m200 — Completed
• Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers — Stopped early
• Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers — Completed
• Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia — Completed
• Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia — Completed
• Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age — Completed